IE43488L - Guanidines. - Google Patents

Guanidines.

Info

Publication number
IE43488L
IE43488L IE761510A IE151076A IE43488L IE 43488 L IE43488 L IE 43488L IE 761510 A IE761510 A IE 761510A IE 151076 A IE151076 A IE 151076A IE 43488 L IE43488 L IE 43488L
Authority
IE
Ireland
Prior art keywords
compounds
bicyclo
rhinoviruses
gb1492678a
ncnr
Prior art date
Application number
IE761510A
Other versions
IE43488B1 (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IE43488L publication Critical patent/IE43488L/en
Publication of IE43488B1 publication Critical patent/IE43488B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)

Abstract

The compounds correspond to the formula: <IMAGE> wherein R<1> and R<2> have the meanings given in Claim 1. They are prepared by the action of ammonia on a thiourea R<1>NHC(S)NHR<2> or on a thiouronium salt thereof in the presence of a catalyst or on a carbodiimide R<1>NCNR<2>; resulting bicyclo(2,2,1)-hept-5-enyl compounds can be reduced to the bicyclo(2,2,1)heptanyl compounds. The compounds and their salts have an antiviral activity, especially against rhinoviruses; they can be used for the treatment of rhinovirus infections, as well as for the specific suppression of growth of rhinoviruses in diagnostic investigations and in hospital laboratories. [GB1492678A]
IE1510/76A 1975-08-11 1976-07-08 Guanidine derivatives IE43488B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB33435/75A GB1492678A (en) 1975-08-11 1975-08-11 Guanidine derivatives

Publications (2)

Publication Number Publication Date
IE43488L true IE43488L (en) 1977-02-11
IE43488B1 IE43488B1 (en) 1981-03-11

Family

ID=10352924

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1510/76A IE43488B1 (en) 1975-08-11 1976-07-08 Guanidine derivatives

Country Status (17)

Country Link
JP (1) JPS5225743A (en)
AT (1) AT351045B (en)
AU (1) AU497534B2 (en)
BE (1) BE845052A (en)
CA (1) CA1087180A (en)
CH (1) CH625207A5 (en)
DE (1) DE2635932A1 (en)
DK (1) DK362576A (en)
FI (1) FI762158A (en)
FR (1) FR2320736A1 (en)
GB (1) GB1492678A (en)
IE (1) IE43488B1 (en)
NL (1) NL7608903A (en)
NO (1) NO143993C (en)
PL (1) PL98956B1 (en)
SE (1) SE7608929L (en)
ZA (1) ZA764126B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
US4628061A (en) * 1981-12-23 1986-12-09 National Research Development Corporation Prostaglandins
JPS59501110A (en) * 1982-06-21 1984-06-28 インステイテユ−ト オルガニチエスコゴ シンテザアカデミイ ナウク ラトビスコイ エスエスア−ル Pharmaceutical compositions with antitumor activity
US20060100225A1 (en) * 2004-03-23 2006-05-11 Xi Chen Heteroaryl guanidines; inhibitors of viral replication

Also Published As

Publication number Publication date
ZA764126B (en) 1977-06-29
NO143993C (en) 1981-05-27
NL7608903A (en) 1977-02-15
GB1492678A (en) 1977-11-23
CA1087180A (en) 1980-10-07
BE845052A (en) 1977-02-10
AU1595676A (en) 1978-01-19
AU497534B2 (en) 1978-12-14
FR2320736B1 (en) 1980-11-07
CH625207A5 (en) 1981-09-15
AT351045B (en) 1979-07-10
NO762774L (en) 1977-02-14
SE7608929L (en) 1977-02-12
IE43488B1 (en) 1981-03-11
DE2635932A1 (en) 1977-03-03
FR2320736A1 (en) 1977-03-11
ATA592976A (en) 1978-12-15
NO143993B (en) 1981-02-16
JPS5225743A (en) 1977-02-25
FI762158A (en) 1977-02-12
PL98956B1 (en) 1978-06-30
DK362576A (en) 1977-02-12

Similar Documents

Publication Publication Date Title
Tarail Relation of abnormalities in concentration of serum potassium to electrocardiographic disturbances
ES471981A1 (en) Quinazoline derivatives, process for their preparation, pharmaceutical preparations and their preparation.
ES462065A1 (en) Thiazolidine derivatives
ATE84414T1 (en) USE OF GAMMA-LINOLENIC ACID AND RELATED COMPOUNDS IN THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF COMPLICATIONS OF DIABETES MELLITUS.
Klein et al. The correlation between the inhibition of drug resistance and synergism in streptomycin and penicillin
BG47498A3 (en) Method for preparing of derivatives of 1h, 3h pyrolo (1, 2- c) thiazol
ES472847A1 (en) 2-Bromo-ergosine and its acid addition salts, method for its preparation and its application as a medicine.
IE43488L (en) Guanidines.
JPS5665822A (en) Interferon stabilizing agent
HUT56548A (en) Process for producing n-(2-substituted alkyl)-n&#39;-)imidazol-4-ylalkyl)-guanidine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE3062731D1 (en) Azolyl-alkenols, process for their preparation and their use as fungicides
Hrenoff et al. In vitro and in vivo Studies of a New Antibiotic, Fumagillin, with Endamoeba histolytica.
ES8103031A1 (en) Guanidines, process for their preparation, pharmaceutical preparations containing such compounds and their application.
ES477302A1 (en) Benzenesulfonyl ureas
GB1142220A (en) Skin treatment agent
ES8200684A1 (en) Benzene-sulfonyl ureas, processes for their preparation, pharmaceutical compositions based on these compounds and their use.
EP0299076A4 (en) 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
ES472528A1 (en) Derivatives of benzenesulfonamide, method for their preparation and pharmaceutical compositions containing them.
SU1685454A1 (en) Burn treatment agent &#34;xymedon&#34;
ES481271A1 (en) Derivatives of L-cysteine, their use as medicaments and process for their preparation.
NO921723L (en) NEW QUINOL COMPOUNDS, THE PROCEDURE FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE
ATE22009T1 (en) USE OF ALPHA, ALPHADIALKYLADAMANTYLETHYLAMINES IN THE TREATMENT OF MEASLES VIRUS.
SU682235A1 (en) Composition for the preparation of graduation solution for photoelectrocalorimeters for the determination of hemoglobin in blood
ES423342A1 (en) Substituted guanidine compounds
GB1470747A (en) Pyridazine derivative